We are live on ! Find out more
SNDX icon

Syndax Pharmaceuticals
SNDX

97 hedge funds and large institutions have $484M invested in Syndax Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 47 increasing their positions, 13 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

372% more call options, than puts

Call options by funds: $13.1M | Put options by funds: $2.79M

262% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 13

112% more capital invested

Capital invested by funds: $228M → $484M (+$256M)

93% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 15

21.76% more ownership

Funds ownership: 68.68% → 90.44% (+22%)

17% more funds holding

Funds holding: 83 → 97 (+14)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
97
Holders Change
+14
Holders Change %
+16.87%
% of All Funds
1.99%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
29
Increased
47
Reduced
13
Closed
15
Calls
$13.1M
Puts
$2.79M
Net Calls
+$10.4M
Net Calls Change
+$4.36M

Top Buyers

Rank Fund Capital Flow
1
BC
Boxer Capital
California
+$23.8M
2
APM
Avidity Partners Management
Texas
+$23.3M
3
Citadel Advisors
Citadel Advisors
Florida
+$15.7M
4
RCM
RA Capital Management
Massachusetts
+$15.6M
5
O
OrbiMed
New York
+$12.2M

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$5.98M
2
BlackRock
BlackRock
New York
-$4.05M
3
GTC
Ghost Tree Capital
New York
-$990K
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$891K
5
BCM
Bridgeway Capital Management
Texas
-$867K
Name Holding Trade Value Shares
Change 		Change in
Stake
ACP
26
Acuta Capital Partners
California
$3.57M +$3.67M +240,744 New
Hudson Bay Capital Management
27
Hudson Bay Capital Management
Connecticut
$3.26M +$3.36M +220,300 New
SFM
28
Sphera Funds Management
Israel
$3.26M +$2.31M +151,866 +223%
Two Sigma Advisers
29
Two Sigma Advisers
New York
$2.97M +$2.27M +149,000 +289%
GTC
30
Ghost Tree Capital
New York
$2.74M -$990K -65,000 -26%
Macquarie Group
31
Macquarie Group
Australia
$2.67M – – –
Assenagon Asset Management
32
Assenagon Asset Management
Luxembourg
$2.64M +$2.71M +178,192 New
Morgan Stanley
33
Morgan Stanley
New York
$2.22M +$1.21M +79,301 +112%
PAI
34
Palo Alto Investors
California
$1.89M +$938K +61,600 +93%
N
35
Nuveen
North Carolina
$1.74M +$644K +42,266 +56%
Russell Investments Group
36
Russell Investments Group
United Kingdom
$1.54M -$462K -30,327 -23%
Bank of New York Mellon
37
Bank of New York Mellon
New York
$1.53M +$319K +20,919 +25%
D.E. Shaw & Co
38
D.E. Shaw & Co
New York
$1.49M +$351K +23,018 +30%
Renaissance Technologies
39
Renaissance Technologies
New York
$1.4M -$5.98M -392,900 -81%
SI
40
Sofinnova Investments
California
$1.36M +$1.4M +91,964 New
Wells Fargo
41
Wells Fargo
California
$1.29M +$954K +62,660 +254%
PAM
42
Panagora Asset Management
Massachusetts
$1.03M – – –
Charles Schwab
43
Charles Schwab
California
$985K +$162K +10,661 +19%
California Public Employees Retirement System
44
California Public Employees Retirement System
California
$883K +$688K +45,191 +314%
CS
45
Credit Suisse
Switzerland
$770K +$791K +51,934 New
Barclays
46
Barclays
United Kingdom
$736K +$620K +40,707 +455%
Los Angeles Capital Management
47
Los Angeles Capital Management
California
$726K +$294K +19,300 +65%
Simplex Trading
48
Simplex Trading
Illinois
$691K +$405K +26,617 +133%
Citigroup
49
Citigroup
New York
$687K +$623K +40,872 +743%
Bank of America
50
Bank of America
North Carolina
$679K +$288K +18,923 +70%
1
2
3 4 5

SNDX Hedge Fund Activity: Q2 2020 in Review

97 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Syndax Pharmaceuticals (SNDX) for Q2 2020, worth a combined $484M — up 112% from $228M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new SNDX positions and 15 closed out — a net gain of 14 holders — while 47 added to existing stakes and 13 trimmed.

The largest buyer was Boxer Capital, adding an estimated $23.8M. The largest seller was Renaissance Technologies, cutting an estimated $5.98M.

  • 97 institutional investors held Syndax Pharmaceuticals (SNDX) as of Q2 2020, up from 83 in Q1 2020.
  • Funds reported $484M of Syndax Pharmaceuticals stock for Q2 2020, up 112% quarter-over-quarter.
  • 29 funds opened new Syndax Pharmaceuticals positions in Q2 2020 and 15 closed out, a net change of +14 holders.
  • The largest Syndax Pharmaceuticals buyer in Q2 2020 was Boxer Capital, an estimated $23.8M added.
  • The largest Syndax Pharmaceuticals seller in Q2 2020 was Renaissance Technologies, an estimated $5.98M sold.

Based on aggregated 13F filings for Q2 2020.